2019 Vancouver – the Combined Scientific Conference of IACR and NAACCR

2019 Vancouver: the Combined Scientific Conference of NAACCR and IACR

June 9-13, 2019

The combined conference of North American Association of Central Cancer Registries (NAACCR) and IACR (International Association of Cancer Registries) for 2019 is a unique opportunity for professionals to network with colleagues conducting similar work globally. The conference is taking place June 9 – 13, 2019, in Vancouver, British Columbia, Canada.

The conference programme is available here:  https://www.naaccr.org/naaccr-iacr2019/#program


Epidemiologic Studies Using Cancer Surveillance Data

  • Descriptive Epidemiology
  • Cohort Studies
  • Survival Studies
  • Cancer in special populations
  • Cancer in populations around the world
  • Cancers with changing or unusual patterns

New Directions

  • Visioning the future of cancer surveillance
  • Tissue repositories, biomarkers, prognostic factors
  • Technologic and scientific advances and innovations
  • New and emerging methods of data collection
  • Data collection in rural and remote areas

Tools for Cancer Registries

  • Statistical tools and methods
  • Estimating prevalence
  • Data visualization tools
  • Trends, projections, and estimating cancer burden
  • Innovative analytical methods

Childhood Cancers

  • Staging system
  • Surveillance issues specific to children
  • Epidemiology

Challenges & Solutions in Data Management

  • Using ancillary systems for core data management
  • Maintaining privacy & confidentiality
  • Variables for core cancer dataset
  • Transitioning to XML

Advanced Data Collection

  • Updates on international staging systems
  • Collection of recurrence and progression data
  • Collection of Treatment data

Data Collection and Operations

  • Data quality, control, & standards
  • Innovative data collection and/or consolidation
  • Overcoming issues with data sharing

Cancer Control

  • Targeting populations for intervention
  • Approaches for estimating cancer burden
  • Using registry data in a clinical setting
  • Obesity, HPV, or tobacco-associated cancers